Hyperlipidemia Drug Market - Familial Cholesterol Disorders and Genetic Dyslipidemia Treatment
Market Overview The global Hyperlipidemia Drug Market is experiencing explosive growth driven by familial cholesterol disorder recognition, genetic dyslipidemia treatment advancement, and precision lipidology emergence. The global hyperlipidemia drug market is projected to exceed USD 30 billion through 2030, fueled by homozygous familial hypercholesterolemia therapies, genetic screening...
0 Kommentare 0 Geteilt 2 Ansichten 0 Bewertungen